Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population
Clinical trial NCT01041573 · COMPLETED
Trial details
- NCT number
- NCT01041573
- Sponsor
- Valneva Austria GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2011-02-01
- Enrollment
- 1869
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.